CAMBELL INTERNATIONAL HOLDING CORP.

CIK: 1678848 Filed: September 9, 2025 10-K

Key Highlights

  • Partnered with labs to launch science-backed peptide drinks and herbal concentrates for digestion and stomach health.
  • Maintains a dedicated R&D team creating 'small molecule' health drinks, unusual for supermarkets.
  • Collaborates with industry leaders like China Polypeptide Industry Group, enhancing credibility.

Financial Analysis

CAMBELL INTERNATIONAL HOLDING CORP. Annual Review – Plain English Summary

Let’s cut through the noise. Here’s what you actually need to know about Campbell’s year:


What They Do (And Why It Matters)

Campbell runs Baijiakang Healthy Lifestyle Supermarkets in China, targeting middle-aged/elderly customers with a twist:

  • Stores offer health screenings, therapy sessions, and nutrition advice alongside shopping
  • Sells premium carrot juice (85% veggie content, rich in natural beta-carotene)
  • Mobile app for memberships and online orders

Why this works: China’s health food market is booming—projected to hit $34 billion by 2025 (30% growth!). Campbell’s betting on aging populations and wellness trends.


The Big Wins

  1. Science-backed products: Partnered with labs to launch peptide drinks (digestion aid) and herbal concentrates (stomach health).
  2. R&D edge: Maintains a dedicated research team (unusual for supermarkets), creating “small molecule” health drinks.
  3. Street cred: Collaborates with industry leaders like China Polypeptide Industry Group.
  4. Regulatory safe: Fully licensed in China’s complex system—no shutdown risks.

The Stumbles

  1. Store growth lagged: Only 150+ franchise stores (below goals). Switching to company-owned stores for better control.
  2. Premium pricing: Their carrot juice costs 2-3x more than competitors (Huiyuan/Weiquan) due to natural ingredients. Great for quality, tough for budget shoppers.

What Keeps Them Up at Night

  1. Regulatory roulette: China could demand new permits (health data, product claims), raising costs.
  2. Lawsuit risks: Even minor customer disputes could drain cash and management time.
  3. Shareholder sales: 7.25M shares exist—if big investors sell, stock price could drop.
  4. Global chaos: Ukraine war impacts energy/transport costs. New pandemics or black swan events could disrupt supply chains.

Future Plans

  1. Own all stores: Ditch franchises to control quality.
  2. Health-tech mix: Expand in-store screenings + app health tracking.
  3. Science snacks: Push peptide powders and herbal concentrates.
  4. Carrot juice dominance: Leverage “85% veggie” angle vs. rivals’ fruit-heavy blends.

The Bottom Line for Investors

👍 Upside: Unique health-focused model, aging population tailwinds, strong R&D partnerships, tax benefits.
👎 Risks: Premium pricing in a cost-sensitive market, store conversion costs, global economic fragility.

Watch closely in 2024:

  • How smoothly they transition to company-owned stores
  • If sales grow despite higher prices
  • Customer reactions to new science-based products
  • Any regulatory fines or shareholder stock dumps

Final Takeaway:
Campbell’s trying to carve out a premium health niche in a booming market, but execution risks are high. The stock could reward patience if they nail their store strategy and justify premium pricing. Not for risk-averse investors.

Always do your own research—this isn’t financial advice, just a friendly breakdown! 😊

Risk Factors

  • Premium pricing strategy (carrot juice costs 2-3x competitors) may limit budget-conscious customers.
  • Regulatory risks in China, including potential new permit requirements increasing costs.
  • Shareholder sales of 7.25M shares could depress stock prices.

Financial Metrics

Revenue
Net Income
Growth Rate

Document Information

Analysis Processed

September 14, 2025 at 12:57 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.